1990

• Badimon JJ, Badimon L, Fuster V
  Regression of atherosclerotic lesions by high density lipoprotein plasma fraction in the cholesterol-fed rabbit
  Journal Clinical Investigation 85, 1234-1241, 1990.
  
  
• Lassila R, Badimon JJ, Vallabhajosula S, Badimon L
  Dynamic monitoring of platelet deposition on severely damaged vessel in flowing blood. Effects of different stenoses on thrombus growth.
  Arteriosclerosis 10, 306-315, 1990.
  
  
• Chesebro JH, Badimon L, Fuster V
  New approaches to treatment of myocardial infarction
  American Journal of Cardiology 65, 12C-19C, 1990.
  
  
• Ip JH, Fuster V, Badimon L, Badimon JJ, Taubman MB, Chesebro JH
  Syndromes of accelerated atherosclerosis: role of vascular injury and smooth muscle cell proliferation
  Journal of the American College of Cardiology 15, 1667-1687, 1990.
  
  
• Fuster V, Stein B, Ambrose JA, Badimon L, Badimon JJ, Chesebro JH
  Atherosclerotic plaque rupture and thrombosis. Evolving concepts
  Circulation 82, II47-II59, 1990.
  
  
• Sanborn TA, Alexopoulous D, Marmur JD, Kahn H, Badimon JJ, Badimon L, Fuster V
  Coronary excimer laser angioplasty: reduced complications and In111-platelet accumulation compared with thermal laser angioplasty.
  Journal of the American College of Cardiology 16, 502-506, 1990.
  
  
• Badimon L, Badimon JJ, Fuster V
  Thrombogenesis and inhibition of platelet aggregation. Experimental aspects and future approaches
  Z. Kardiologie 79, 133-145, 1990.
  
  
• Heras M, Chesebro JH, Webster MWI, Mruk JS, Grill DE, Penny WJ, Bowie EJW, Badimon L, Fuster V
  Hirudin, heparin and, placebo during deep arterial injury in the pig: The in vivo role of thrombin in platelet mediated thrombosis
  Circulation 82, 1476-1484, 1990.
  
  
• Badimon JJ, Ip JH, Badimon L, Fuster V
  Thrombosis and accelerated atherosclerosis in coronary bypass surgery and restenosis after Percutaneous Transluminal Coronary Angioplasty : Implications for therapy.
  Coronary Artery Disease 1, 170-179, 1990
  
• Badimon JJ, Fuster V, Badimon L
  Accelerated atherosclerosis and thrombosis in coronary bypass surgery and restenosis after PTCA:Implications for therapy
  Clínica e Investigación en Arterioclerosis 2: 107-114, 1990
  
  
• Badimon L, Badimon JJ, Turitto VT, Fuster V
  Platelet interaction to prosthetic materials. Role of von Willebrand factor in platelet interaction to PTFE
  Journal of Biomaterials Applications 5, 27-48, 1990
  
  
• Israel DH, Fuster V, Chesebro JH, Badimon L
  Antithrombotic therapy for coronary artery disease and valvular heart disease.
  In: Baillière's Clinical Haematology
  Ed Baillière Tindall (Vol. 3) (Chapter 12) pp 705-743, 1990.
  
  
• Badimon JJ, Badimon L
  Inhibitory effects of High-Density lipoprotein in experimental atherosclerosis
  In: Reversing atherosclerosis. What is the role of HDL?
  Eds. Proc. Symposium 1989
  Linkoping, Sweden, pp 32-37, 1990.
  
  
• Badimon JJ, Badimon L, Fuster V
  Lipoproteins and atherosclerosis: Role of plasma high density lipoprotein fractions.
  In: Karolinska Hospital 50 Years. Disorders of HDL
  Ed. LA Carlson. Smith-Gordon Co Ltd and Nishimura Co Ltd., Stockholm (Chapter 31)
  pp 233-242 , 1990
  
  
• Badimon L, Lassila R, Badimon JJ, Ruggeri Z, Chesebro J, Fuster V
  Platelet deposition on severely damaged vessel wall at flow conditions typical of stenotic vessel is inhibited by LJ-CP3. (Antiplatelet glycoprotein GPIIB/IIIA monoclonal antibody).
  Journal of the American College of Cardiology, 15:188A, 1990
  
  
• Badimon L, Lassila R, Badimon J, Fuster V
  An acute surge of epinephrine stimulates platelet deposition to severely damaged vascular wall.
  Journal of the American College of Cardiology;15:#181A, 1990
  
  
• Heras M, Chesebro JH, Mark WI, Webster MB, Mruk JS, Grill DE, Badimon L, Fuster V
  Antithrombotic efficacy of low molecular weight heparin after arterial injury in the pig.
  Journal of the American College of Cardiology ;15:188A, 1990
  
  
• Badimon L, Badimon J, Ruggeri Z, Fuster V
  A peptide-specific monoclonal antibody that inhibits von Willebrand factor binding to GPIIb/IIIa [152B6] inhibits platelet deposition to human atherosclerotic vessel wall.
  Circulation; 82:4,III-370 [ # 1470], 1990
  

1991

• Badimon L, Merino A, Badimon JJ, Fuster V
  Hirudin and other thrombin inhibitors: experimental results and potential clinical applications
  Trends in Cardiovascular Medicine 1, 261-267, 1991.
  
  
• Badimon JJ, Badimon L, Turitto VT, Fuster V
  Platelet deposition at high shear rates is enhanced by high plasma cholesterol levels. In vivo study in the rabbit model
  Arteriosclerosis and Thrombosis 11, 395-402, 1991.
  
  
• Alexopoulos D. Sanborn TA, Badimon JJ, Badimon L, Dische R, FusterV.
  Coronary laser thermal angioplasty in the swine: Reduced complications with shorter laser delivery time.
  Journal of Interventional Cardiology 4, 189-197, 1991.
  
  
• Ip JH, Stein B, Fuster V, Badimon L.
  Antithrombotic therapy in cardiovascular diseases. Future directions based on pathogenesis and risk.
  Annals of the New York Academy of Sciences 614, 289-311, 1991.
  
  
• Ip JH, Fuster V, Israel D, Badimon L, Badimon JJ, Chesebro JH
  The role of platelets, thrombin and hyperplasia in restenosis after coronary angioplasty
  Journal of the American College of Cardiology 17, 77B-88B, 1991.
  
  
• Fuster V, Badimon L, Badimon JJ, Ip JH, Chesebro JH
  The porcine model for the understanding of thrombogenesis and atherogenesis
  Mayo Clinic Proceedings 66, 818-831, 1991.
  
  
• Marmur JD, Sanborn TA, Kahn H, Badimon JJ, Badimon L, Fuster V
  Acute biologic response to excimer versus thermal laser angioplasty in experimental atherosclerosis.
  Journal of the American College of Cardiology 17, 978-984, 1991.
  
  
• Fuster V, Ip JH, Badimon L, Badimon JJ,Stein B, Chesebro JH
  Importance of experimental models for the development of clinical trials on thromboatherosclerosis
  Circulation 83, IV15-IV25, 1991.
  
  
• Badimon L, Badimon JJ, Lassila R, Heras M, Chesebro JH, Fuster V
  Thrombin regulation of platelet interaction with damaged vessel wall, and isolated collagen type I at arterial flow conditions in a porcine model : Effects hirudins, heparin and calcium chelation.
  Blood 78, 423-434, 1991.
  
  
• Chesebro JH, Badimon L, Fuster V
  Importance of antithrombin therapy during coronary angioplasty
  Journal of the American College of Cardiology 17, 96B-100B, 1991.
  
  
• Chesebro JH, Zoldhelyi P, Badimon L, Fuster V
  Role of Thrombin in arterial thrombosis. Implications for therapy.
  Thrombosis and Haemostasis 66, 1-5, 1991.
  
  
• Badimon L, BadimonJJ, Cohen M, Chesebro JH, Fuster V.
  Vessel wall-related risk factors in acute vascular events
  Drugs 42, 1-9, 1991.
  
  
• Lam J, Chesebro JH,Steele P,Heras M, Webster MWI, Badimon L,Fuster V
  Antithrombotic therapy for deep arterial injury by angioplasty: Efficacy of common platelet inhibition compared with thrombin inhibition pigs
  Circulation 84, 814-820, 1991
  
• Ip JH, Fuster V, Badimon L
  Thrombosis and antithrombotic therapy in cardiovascular disease.
  Cardiovascular Reviews and Reports 12, 16-30, 1991.
  
  
• Badimon L, Merino A, Badimon JJ
  Trombosis arterial y activación plaquetar.I. Fisiopatología
  Revista Iberoamericana de Trombosis y Hemostasia 4: 73-80, 1991.
  
  
• Badimon L, Merino A, Badimon JJ, Fuster V:
  Trombosis arterial y activación plaquetar.II. Tratamiento antitrombótico.
  Revista Iberoamericana de Trombosis y Hemostasia 4: 81-88, 1991
  
  
• Stein B, Fuster V, Israel DH, Cohen M, Badimon L, Badimon JJ, Chesebro JH
  Platelet inhibitor drugs in cardiovascular disease: An update
  In: An Era In Cardiovascular Medicine.
  Ed Knoebel S, Dack S.
  Elsevier Science Publishing Co, Inc; pp 129-153, 1991.
  
  
• Badimon JJ, Badimon L
  Metabolismo de la Pared Arterial
  En : Colesterol y Arteriosclerosis [Curso de Formación Continuada de S.E.A.]
  Ed. J. Gomez Gerique. pp-9-25, 1991
  
  
• Ip JH, Stein B, Foster V, Badimon L
  Antithrombotic therapy in Cardiovascular Diseases: Future directions Based on Pathogenesis and Risk.
  In: Progress in Vascular Biology, Haemostasis and Thrombosis. Theodore S. Zimmerman Memorial Conference.
  Eds.Ruggeri ZM, Fulcher CA and Ware J.
  NY Acad Sci Press. v.614 pp 289-311, 1991.
  
  
• Israel DH, Fuster V, Badimon L, Badimon JJ, Chesebro JH
  Antithrombotic therapy in coronary artery disease and coronary intervention
  In: Textbook of Hematology.
  Eds: Kwaan HC, Kucuk O, Terebelo H
  CRC-Press, Boca Raton, Fl. 1991
  
  
• Badimon J, Fuster V, Badimon L
  Inhibition of Glycoprotein Ib binding domain inhibits platelet deposition on damaged vessel wall.
  Circulation 84, 4:,I-162 [# 980], 1991
  
  
• Webster M, Chesebro J.H., Grill D.E, Badimon JJ, Badimon L, FusterV.
  The thrombotic and proliferative response to angioplasty in pigs after deep arterial injury: Effect of intravenous thrombin inhibition with hirudin.
  Circulation 84(Suppl II),II-580.[# 2306]. 1991
  
  
• Badimon L, Badimon JJ, Chesebro JH, Fuster V
  Inhibition of thrombosis at sites of severe wall injury: Thrombin versus ligand integrin inhibition.
  Circulation 84(Suppl II):II-581. [# 2310], 1991
  

1992

• Badimon L, Badimon JJ, Penny W, Webster MW, Chesebro JH, Fuster V.
  Endothelium and atherosclerosis
  Journal of Hypertension 10 , S43-S50, 1992.
  
  
• Badimon JJ, Badimon L.
  High density lipoproteins and risk of coronary heart disease.
  Cardiovascular Risk Factors, 5, 307-318, 1992
  
  
• Fuster V, Badimon L, Badimon JJ, Chesebro JH.
  The pathogenesis of coronary artery disease and the acute coronary syndromes. (Part I)
  New England Journal of Medicine 326, 242-250, 1992.
  
  
• Fuster V, Badimon L, Badimon JJ, Chesebro JH.
  The pathogenesis of coronary artery disease and the acute coronary syndromes. (Part II)
  New England Journal of Medicine 326, 310-318, 1992.
  
  
• Badimon L, Chesebro JH, Badimon JJ
  Thrombus formation on ruptured atherosclerotic plaques and rethrombosis on evolving thrombi
  Circulation 86, III-74-III-85, 1992
  
  
• Fuster V, Badimon JJ, Badimon L
  Clinical-Pathological correlations of coronary disease progression and regression
  Circulation 86, III-1-III-11, 1992
  
  
• Merino A,Hauptman P,Badimon L, Badimon JJ, Cohen M, Fuster V, GoldmanM
  Echocardiographic "Smoke" is produced by an interaction of erythrocytes and plasma proteins modulated by shear forces.
  Journal of the American College of Cardiology 20, 1661-1668, 1992
  
  
• Badimon JJ, Fuster V, Badimon L
  Role of high density lipoproteins in the regression of atherosclerosis.
  Circulation 86, III-86-III-94, 1992
  
• Chesebro JH, Webster MW I, Zoldhely P, Roche PC, Badimon L, Badimon JJ.
  Antithrombotic therapy and progression of coronary artery disease: Antiplatelet versus antithrombin.
  Circulation 86, III-100-III-111, 1992
  
  
• Apitz-Castro R, Badimon JJ, Badimon L
  Effect of ajoene, the major antiplatelet compound from garlic, on platelet thrombus formation.
  Thrombosis Research 68, 145-155, 1992
  
• Heras M, Badimon L
  Protocolos de prevención y tratamiento de la enfermedad tromboembólica. Editorial.
  Clínica e Investigación en Arterioclerosis, 4, 1, 37-39, 1992
  
  
• Badimon L, Badimon JJ, Gold HK, Fuster V.
  Coronary Atherosclerosis : Morphology and characteristics to identify by evolving imaging technology.
  American Journal of Cardiac Imaging 6, 278-288, 1992
  
  
• Badimon L
  Determinants of coronary thrombosis in acute myocardial infarction.
  In: Cardiology Today and Tomorrow
  Eds S. Chierchia, A. Grossi
  Centro Scientifico Editore, Torino; pp 45-54, 1992.
  
• Badimon L, Fuster V
  von Willebrand Factor and atherosclerotic cardiovascular disease
  In: Atherosclerotic Cardiovascular Disease, Hemostasis, and Endothelial Function.
  Ed. R.B.Francis.Jr
  Ed. Marcel Dekker, Inc. (Chapter 3) pp 53-85, 1992
  
  
• Badimon L ,Badimon JJ, Fuster V
  Pathogenesis of Thrombosis.
  In: Thrombosis in Cardiovascular Disorders
  Eds. Fuster V, Verstraete M.
  W.B. Saunders Company, Philadelphia, (Chapter 2) pp 17-39, 1992
  
  
• Badimon L
  Patogenia de la enfermedad coronaria. Formación de la placa de ateroma.
  En : Lípidos y Enfermedad Coronaria
  Ed. Navarro López, F.
  Ed. SEC / SEA, pp 1-36, 1992
  
  
• Badimon L, Badimon JJ.
  Changes in vascular geometry in atherosclerotic plaque rupture and its relationship to thrombosis in acute vascular events.
  In : Advances in Cardiovascular Engineering.
  Eds. NHC Hwang, VT Turitto, MRT Yen (Proc. of ASI, Málaga, Spain, 1991)
  Ed.Plenum Press, New York / NATO Scientific Affairs Division, pp 175-187, 1992
  
  
• Merino A, Cohen M, Badimon J, Fuster V, Badimon L
  Synergistic action of severe wall injury and shear forces on thrombus formation in arterial stenosis: Definition of a shear rate threshold.
  Journal of the American College of Cardiology, 19 (Suppl A):329A, 1992
  

1993

• Simon JJ, Fuster V, Chesebro JH, Badimon L
  Conary atherosclerosis: A multifactorial disease.
  Circulation 87, II-3-II-16, 1993
  
  
• Badimon L, Badimon JJ, Fuster V.
  Atherosclerosis and thrombosis in the coronary arteries
  Cardiovascular Risk Factors, 3 : 379-386; 1993
  
  
• Lam JYT, Chesebro JH, Badimon L, Fuster V.
  Exogenous prostacyclin decreases vasoconstriction but not platelet thrombus deposition after arterial injury.
  Journal of the American College of Cardiology 21, 488-492, 1993
  
  
• Badimon L, Badimon JJ, Chesebro JH, Fuster V.
  von Willebrand factor and cardiovascular disease.
  Thrombosis and Haemostasis, 70, 111-118, 1993
  
  
• Badimon L, Badimon JJ.
  Regresión de la placa de ateroma
  Medicine, 6: 1843-1849, 1993
  
  
• Badimon L.
  Patogénesis de la lesión arteriosclerótica : ruptura de la placa y papel de la trombosis en la progresión de la lesión.
  Cardiovascular Risk Factors, 2: 387-389, 1993
  
• Badimon JJ, Badimon L
  Acidos grasos poliinsaturados omega-3 y arteriosclerosis. Editorial.
  Clínica e Investigación en Arteriosclerosis, 5: 84-85, 1993
  
  
• Chesebro JH, Badimon JJ, Badimon L, Fuster V.
  Anticoagulant and antiplatelet therapy in acute coronary syndromes and atrial fibrillation.
  Cardiology in Review, 1, 167-176, 1993
  
  
• Badimon L, Chesebro JH, Badimon JJ, Fuster V.
  Arterial angioplasty : Thrombosis and Restenosis
  Journal of Physiology and Pharmacology , 44;3 : 89-192, 1993
  
  
• Badimon L, Badimon JJ.
  Atherosclerosis y trombosis en la enfermedad coronaria.
  Arquivos de Medicina, 7 (suppl. 8): 26-35, 1993
  
  
• Chesebro JH, Badimon JJ, Badimon L, Fuster V.
  Arterial angioplasty : Injury, mural thrombus, and restenosis.
  In: The practice of Interventional Cardiology.
  Eds. Vogel JHK, King III SP.
  Ed. Mosby Year Book Inc. (Chapter 45) pp 509-520 , 1993
  
  
• Chesebro JH, Webster MW, Zoldhelyi P, Badimon JJ, Badimon L, Fuster V.
  Thrombosis and restenosis after angioplasty.
  In : Coronary Restenosis
  Eds. Robert S. Schwartz
  Ed. Blackwell Scientific Publications / EE.UU. (Chapter 9) pp 219-237, 1993
  
  
• Badimon JJ, Badimon L,Fuster V,
  Aterogenesis : Implicaciones del colesterol en la formación, progresión y regresión de la placa de ateroma.
  En: Hipercolesterolemias / Monografias Clínicas en Atención Primaria
  Eds. Pinto X, Brotons C.
  Editorial Doyma, S.A., Barcelona (Capítulo 4) pp-53-66 , 1993
  
  
• Heras M, Badimon L
  Restenosis coronaria postangioplastia: ¿ endotelio, plaqueta o célula muscular lisa?
  En : Avances y Dilemas en Cardiología.
  Eds C. Saez de la Calzada.
  Editorial C.E.A, SA, Madrid, (Capítulo 34) pp 188-193 ; 1993
  
  
• Badimon L, Badimon JJ
  Arteriosclerosis y Trombosis.
  En : Enciclopedia Hematológica Iberoamericana - V Centenario
  Ed A.López Borrasca.
  Universidad de Salamaca, 1993
  
  
• Badimon L, Fuster V
  Combinaciones de drogas en el tratamiento antitrombotico
  En : Enciclopedia Hematológica Iberoamericana - V Centenario
  Ed A.López Borrasca.
  Universidad de Salamanca, 1993
  
  
• Badimon JJ, Weng D, Fuster V, Badimon L.
  Inhibition of platelet arterial thrombosis on severely injured vessel wall by a thrombin specific synthetic peptide.
  Journal of the American College of Cardiology, 21 :211A (#900-39) 1993.
  
  
• Badimon JJ, Fuster V, Chesebro JH, Badimon L.
  Effect of depth of arterial injury on kinetics of fibrinogen deposition in arterial thrombosis.
  Thrombosis and Haemostasis, 69: 6, 796 (# 905), 1993.
  
  
• Badimon L, Fuster V, Chesebro JH, Badimon JJ.
  Kinetics of fibrinogen deposition on stenotic damaged vessel wall in arterial thrombosis .
  Thrombosis and Haemostasis, 69: 6, 813 (# 967), 1993.
  
  
• Colomé C, Mendieta A, Badimon L.
  Funcionalismo de las células del linaje monocito-macrofago : Marcaje con la sonda fluorescente CMAC.
  Clin. Invest. Arteriosclerosis, 5 (supl 2) (# O16), 1993.
  
  
• Viñals M, Martínez J, Badimon JJ, Badimon L.
  Efecto de las lipoproteinas de alta densidad HDL-VHDL en la expresión pulmonar de prostaglandin sintetasa mRNA (COX-mRNA).
  Clin. Invest. Arteriosclerosis, 5 (supl 2) (# O14), 1993.
  
  
• Varela O, Royo T, Badimon L.
  Actividad proliferativa producida por la trombina en células musculares lisas de origen porcino y humano.
  Clin. Invest. Arteriosclerosis, 5 (supl 2) (# O15), 1993.
  
  
• Martínez J, Varela O, Badimon L.
  Supresión del crecimiento de células musculares lisas por inhibidores de la HMG-CoA reductasa.
  Clin. Invest. Arteriosclerosis, 5 (supl 2) (# O18), 1993.
  
  
• Mendieta A, Colomé C, Martínez J, Badimon L.
  Las lipoproteinas de alta densidad inducen la expresión de ciclooxigenasa (COX)-mRNA en células del linaje monocito-macrofago.
  Clin. Invest. Arteriosclerosis, 5 (supl 2) (# O20), 1993.
  
  
• Pueyo C, Royo T, Alfón J, Badimon JJ, Badimon L.
  Aterotrombosis : Efecto de la lesión vascular en la cinetica de deposición de fibrinógeno en áreas de estenosis en condiciones normolipémicas.
  Clin. Invest. Arteriosclerosis, 5 (supl 2) (# O17), 1993.
  
  
• Badimon JJ, Weng D, Chesebro JH, Fuster V, Badimon L.
  Combined specific thrombin and cyclooxygenase inhibition reduces arterial platelet deposition more effectively than either alone at high shear rate.
  Circulation, 88 (2) (#2465); 1993
  
  
• Fernández-Ortiz A, Meyer BJ, Mailhac A, Chesebro JH, Badimon L, Hassinger N, Owen WG,Fuster V, Badimon JJ.
  Intravascular local delivery : an iontophoretic Approach.
  Circulation, 88 (2) (#1654); 1993
  
  
• Martínez-González J, Varela O, Badimon L.
  Supression of smooth muscle cells growth by HMG-CoA reductase inhibitors.
  LIAC, Lyon, F, (#16), 1993
  
  
• Pueyo C, Martínez-González J, Royo T, Alfon J, Badimon JJ, Badimon L.
  Kinetics of fibrinogen deposition on vascular injury and stenotic areas in normolipemic condictions.
  LIAC, Lyon, F, (#39), 1993
  

1994

• Fernández-Ortiz A, Meyer BJ, Mailhac A, Falk E, Badimon L, Fuster V, Chesebro JH, Badimon JJ.
  A new approach for local intravascular drug delivery : iontophoretic balloon.
  Circulation, 89: 1518-1522; 1994
  
  
• Alexopoulos D, Sanborn TA, Marmur JD, Badimon JJ, Badimon L, Dische R, Fuster V.
  Acute biological response to laser balloon angioplasty in the atherosclerotic rabbit.
  Laser in Surgery and Medicine, 14:7-12; 1994
  
  
• Badimon L, Badimon JJ.
  Lipoproteínas de alta densidad y riesgo para la enfermedad arterial coronaria.
  Cardiovascular Risk Factors, 3 (2): 3-11; 1994
  
  
• Badimon L, Royo T, Badimon JJ, Chesebro JH, Fuster V.
  Intrinsic thrombus modifications favourishing embolization.
  Giornale Italiano di Cardiologia, 24: 215-224; 1994
  
  
• Badimon JJ, Weng D, Chesebro JH, Fuster V, Badimon L.
  Platelet deposition induced by severely damaged vessel wall is inhibited by a boroarginine synthetic peptide with antithrombin activity.
  Thrombosis and Haemostasis, 71 (4):511-516; 1994
  
  
• Badimon L, Meyer BJ, Badimon JJ.
  Thrombin in arterial thrombosis.
  Haemostasis, 24:69-80; 1994
  
  
• Fernández-Ortiz A, Badimon JJ, Falk E, Fuster V, Meyer B, Mailhac A, Weng D, Shah PK, Badimon L.
  Characterization of the relative thrombogenicity of atherosclerotic plaque components : implications for consequences of plaque rupture.
  Journal of the American College of Cardiology, 23,7 : 1562-1569; 1994
  
  
• Apitz-Castro R, Badimon JJ, Badimon L.
  A garlic derivative, ajoene, inhibits platelet deposition on severely damaged vessel wall in an in vivo porcine experimental model.
  Thrombosis Research 75,3: 243-249; 1994
  
  
• Mailhac A, Badimon JJ, Fallon JT, Fernández-Ortiz A, Meyer B, Chesebro JH, Fuster V, Badimon L.
  Effect of an eccentric severe stenosis on fibrin(ogen) deposition on severely damaged vessel wall in arterial thrombosis. Relative contribution of fibrin(ogen) and platelets.
  Circulation 90: 988-996; 1994
  
  
• Badimon JJ, Badimon L, Fuster V.
  Atherosclerotic disease : role of thrombosis on its progression.
  Cardiovascular Risk Factors, 4:79-91; 1994
  
  
• Merino A, Cohen M, Badimon JJ, Fuster V, Badimon L.
  Synergistic action of severe wall injury and shear forces on thrombus formation in arterial stenosis:definition of a thrombotic shear rate threshold.
  Journal of the American College of Cardiology, 24 : 1091-1094; 1994
  
  
• Meyer BJ, Badimon JJ, Mailhac A, Fernández-Ortiz A, Chesebro JH, Fuster V, Badimon L.
  Inhibition of growth of thrombus on fresh mural thrombus : targeting optimal therapy.
  Circulation, 90: 2432-2438; 1994
  
  
• Meyer BJ, Fernández-Ortiz A, Mailhac A, Falk E, Badimon L, Don Michael A, Chesebro JH,Fuster V, Badimon JJ.
  Local delivery of r-hirudin by a double balloon perfusion catheter prevents mural thrombosis and minimizes platelet deposition after angioplasty.
  Circulation, 90: 2474-2480; 1994
  
  
• Pfliegler G, El-Gamal B, Badimon JJ, Badimon L, Crawford N.
  Inhibition of platelet recuitment to arterial lesions by predeposition of platelets containing encapsulated iloprost.
  Thrombosis and Haemostasis, 72: 604-610; 1994
  
• Meyer, BJ, Badimon JJ, Badimon L.
  La thrombine et les antithrombines en thrombose artérielle.
  Sang Thrombose Vaisseaux, 6: 433-440; 1994
  
  
• Badimon L
  Papel del sistema hemostático en el síndrome de resistencia a la insulina. Estudio en 1500 pacientes con angina pectoris. (Editorial).
  Clinica e Investigación en Arteriosclerosis, 6 (1): 30-32; 1994
  
  
• Badimon L, González Santos P, Cruz Fernández JM, López García-Aranda V.
  Factores que intervienen en la formación y regresión de la placa de ateroma.
  En: Evidencias clinico-experimentales y recomendaciones para el tratamiento de la hiperlipemia en los pacientes con cardiopatía isquémica. Documento Consenso.
  Eds. Sociedad Española de Arteriosclerosis y Sociedad Española de Cardiología.
  Ed. Laboratorios Lacer ; pp 4-5, 1994
  
  
• Badimon L, Colomé C, Mendieta A, Martínez-González J.
  Interacción entre endotelio y monocito en la génesis de la placa de ateroma
  En : Libro de "proceedings" IV Simposio Internacional sobre Lípidos y Aterosclerosis.
  Ed. Universidad Complutense de Madrid/Hospital Universitario San Carlos. pp 13-16; 1994
  
  
• Badimon L, Badimon JJ, Fuster V
  Mechanisms of thrombus formation in the coronary arteries.
  In : Coronary Thrombosis. Intracardiac Thrombosis
  Eds. Pérez Gómez F, Prentice C, Meyer J.
  Ed. Raven Press Ltd., New York, USA (Chapter II), pp 29-50, 1994.
  
  
• Badimon L, Badimon JJ, Fuster V
  Antiplatelet drugs in ischemic heart disease.
  In : Coronary Thrombosis. Intracardiac Thrombosis
  Eds. Pérez Gómez F, Prentice C, Meyer J.
  Ed. Raven Press Ltd., New York, USA (Chapter III), pp 67-80, 1994
  
  
• Fernández-Ortiz A, Badimon JJ, Falk E, Fuster V, Meyer BJ, Mailhac A, Badimon L.
  The lipid-rich core is the most thrombogenic component of human atherosclerotic lesions.
  Journal of the American College of Cardiology, 437A (# 803-3), 1994
  
  
• Meyer BJ, Fernandez-Ortiz A, Badimon L, Michael TD, Fuster V, Chesebro JH, Badimon JJ.
  Local delivery of r-Hirudin by a double balloon perfusion catheter inhibits platelet deposition post angioplasty.
  Journal of the American College of Cardiology, 18A (# 840-29), 1994
  
  
• Meyer BJ, Badimon JJ, Fuster V, Chesebro JH, Badimon L.
  Inhibition of the progression of thrombus growth on pre-existing mural thrombus: targeting optimal therapy.
  Journal of the American College of Cardiology, 64A (# 717-3), 1994
  
  
• Fernández-Ortiz A, Badimon JJ, Falk E, Fuster V, Chesebro JH, Badimon L.
  Thrombogenicity of human arterial wall : implications for vascular interventions.
  Journal of the American College of Cardiology, 184A (# 890-38), 1994
  
  
• Mailhac A, Badimon JJ, Meyer BJ, Fernández-Ortiz A, Fuster V, BadimonL.
  Effect of a severe stenosis on fibrin(ogen) deposition on severely damaged vessel wall in arterial thrombosis.
  Journal of the American College of Cardiology, 41A (# 850-59), 1994
  
  
• Badimon JJ, Fernández-Ortiz A, Meyer B, Mailhac A, Chesebro JH, McBane R, Hassinger N, Falk E, Fallon J, Fuster V, Badimon L.
  Different response to balloon angioplasty of carotid and coronary arteries: acute platelet deposition and intimal thickening.
  Journal of the American College of Cardiology, 234A (# 906-31), 1994
  
  
• Varela O, Royo T, Badimon L.
  Agonist-induced platelet secretion and coronary smooth muscle cell proliferation.
  European Journal of Clinical Investigation, 24 (Suppl 2) 59A (#338), 1994
  
  
• Pueyo C, Alfón J, Royo T, Badimon L.
  Efecto de la hipercolesterolemia sobre la reactividad plaquetaria a substratos vasculares.
  Clinica e Investigación en Arteriosclerosis, 6(1): 50 (# P-F 5), 1994
  
  
• Colomé C, Viñals M, De Castellarnau C, Badimon L.
  Adhesión de monocitos a células endoteliales tratadas con LDL nativas. Efecto de un antioxidante.
  Clinica e Investigación en Arteriosclerosis, 6 (1) : 17 (# F16), 1994
  
  
• Viñals M, Martínez-González J, Badimon JJ, Badimon L.
  Efecto de las lipoproteínas de alta densidad (HDL-VHDL) en la expresión de prostaglandin-sintasa1 mRNA (Cox-1 mRNA) en células musculares lisas.
  Clinica e Investigación en Arteriosclerosis, 6 (1): 49 (#P-F 2), 1994
  
  
• Royo T, Alfon J, Pueyo C, Badimon L.
  Estudios de "binding" del receptor plaquetar GP IIb-IIIa y fibrinógeno en el modelo porcino: influencia de los niveles de LDL en los parámetros cinéticos.
  Clinica e Investigación en Arteriosclerosis, 6 (1) : 14 (# F8), 1994